| abstract |
Disclosed are an antibody targeting PD1, or an antigen-binding fragment thereof, and a bispecific antibody targeting PD1 and OX40, or a fragment thereof. Further disclosed are a nucleic acid molecule encoding the antibody or the antigen-binding fragment thereof, the antibody targeting PD1, or the antigen-binding fragment thereof, the bispecific antibody targeting PD1 and OX40, or the fragment thereof, and the use of the encoding nucleic acid molecule in the treatment, prevention and/or diagnosis of a disease. The disease may be, for example, an immune disease, an acute inflammatory disease, a chronic inflammatory disease or a tumor disease. |